Last edition
News about "STADA Arzneimittel AG"
Bio-Thera, STADA Expand Biosimilars Alliance to Include Tocilizumab
Bio-Thera Solutions and STADA Arzneimittel have extended their biosimilars alliance to include tocilizumab, with Bio-Thera handling development and supply while STADA secures exclusive commercialization rights across Europe and select markets.
STADA Arzneimittel AG | 25/08/2025 | By Mrinmoy Dey | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members